OA
IMGN

Oracle Alpha’s Immunogen Inc IMGN Stock Holding History

Oracle Alpha’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,322
Closed -$336K – 276
2023
Q4 		$336K Buy
+11,322
New +$225K 0.43% 84

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oracle Alpha's IMGN Position: Q1 2024 in Review

Oracle Alpha sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 11,322 shares — an estimated $336K sold.

Oracle Alpha first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $336K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Oracle Alpha reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Oracle Alpha sold 11,322 Immunogen Inc shares in Q1 2024, an estimated $336K.
  • Oracle Alpha first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Oracle Alpha's Immunogen Inc position peaked at $336K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.